Digital Interventions for Relapse Prevention in Adolescence

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-19
SponsorUniversity of Oslo

About this trial

Some adolescents experience periods of anxiety and/or depression, and some find that these periods return over time. The purpose of this study is to examine whether digital interventions-where individuals work systematically with their own thoughts and feelings during periods when they feel well-can help them maintain well-being for longer.

The study includes adolescents aged 16-19 who have previously experienced episodes of depression and/or anxiety to a degree that led them to seek help (e.g., from a school nurse, general practitioner, health clinic, or child and adolescent mental health service). Through a research app on their smartphones, participants complete tasks and answer questionnaires. The study is fully digital. Some participants meet with a therapist in digital group sessions, while others work independently with the digital content.

We will also examine the cost-benefit aspects of offering such interventions. If the study achieves its goals, digital interventions may eventually become a service offered to adolescents recovering from depression and anxiety.

Eligibility criteria

Qualifiers

Currently in full or partial remission for a minimum of 2 months from a depressive disorder or an anxiety disorder as defined by self-reported scores on RCADS-47: previous episode(s) of t-score > 65 and current t-score =<65.

Native or fluent Scandinavian language skills.

Willingness to take part even when allocated to the non-preferred arm of the trial.

Disqualifiers

Ongoing depressive disorder, ongoing anxiety disorder as defined by current t-score =<65 on RCADS-47.

Recent completion of one of the interventions in the two interventional arms.

no available smartphone.

Trial design

Treatments tested in this trial

  • Transdiagnostic app intervention
  • Transdiagnostic mastery course

Treatment groups

495 Participants
are divided into 3 treatment groups

Sponsors and collaborators